Etiometry Platform vs Octagos

Etiometry, founded in 2010 and headquartered in Dedham, aggregates ICU monitor and EHR data into risk indices. Beside its CE Mark it states Health Canada, UAE and Saudi licenses, and a Hamilton Medical partnership for ICU respiratory care was announced in September 2026. An ICU director has no reason to shop Octagos, and a device-clinic cardiologist has none to shop Etiometry.

Octagos is bought by a cardiology practice that runs a device clinic and wants implantable device transmissions triaged. By the vendor's account, Atlas AI makes the first pass, an IBHRE-certified US specialist finalizes the report, and a physician e-signs it. Epic via SMART on FHIR, Oracle Health, athenahealth, medent and NextGen are named, and the vendor states HIPAA compliance plus SOC 2 Type 2 and SOC 3. Its AI overview page makes no regulatory claim for Atlas AI, and openFDA returns no record for Octagos as applicant or device name. A 2025 JACC Advances study tied to the company, summarized by the vendor, reports 99.1% sensitivity against 70.8% for technicians across 690,673 transmissions. Tiers are Pro, Premium, Flex and Custom with no amounts posted.